Bottom line is: I think institutional investors are going to be pragmatic about this. The caravan is moving along. This is the reality.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025